Chung, K.J.* et al. A DEL-1/αvβ3 integrin axis promotes brown adipocyte progenitor proliferation and cold-induced brown adipose tissue adaptation. Mol. Metab. 100:102229 (2025)
Coupland, C. et al. Estrogenic activity of E2-conjugated GLP-1 is mediated by intracellular endolysosomal acidification and estrone metabolism. Mol. Metab. 96:102136 (2025)
Douros, J.D.* et al. A GLP-1 analogue optimized for cAMP-biased signaling improves weight loss in obese mice. Mol. Metab. 100:102124 (2025)
Dreher, S.I.* et al. Sex differences in resting skeletal muscle and the acute and long-term response to endurance exercise in individuals with overweight and obesity. Mol. Metab. 98:102185 (2025)
Finan, B.* et al. A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans. Mol. Metab. 96:102129 (2025)
Hinrichs, A.* et al. Transient juvenile hypoglycemia in GH insensitive Laron syndrome pigs is associated with insulin hypersensitivity. Mol. Metab., DOI: 10.1016/j.molmet.2025.102273:102273 (2025)
Hipp, H. et al. Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 Diabetes. Mol. Metab. 100:102218 (2025)
Lorza-Gil, E. et al. Incretin-responsive human pancreatic adipose tissue organoids: A functional model for fatty pancreas research. Mol. Metab. 91:102067 (2025)
Müller, T.D. et al. Glucose-dependent insulinotropic polypeptide (GIP). Mol. Metab. 95:102118 (2025)
Podraza-Farhanieh, A.* et al. Physical training reduces cell senescence and associated insulin resistance in skeletal muscle. Mol. Metab. 95:102130 (2025)
Prudente de Mello, N. et al. Pervasive glycative stress links metabolic imbalance and muscle atrophy in early-onset Parkinson's disease. Mol. Metab. 97:102163 (2025)
Reiner, J.* et al. Glucagon-like peptide-2 pharmacotherapy activates hepatic Farnesoid X receptor-signaling to attenuate resection-associated bile acid loss in mice. Mol. Metab. 95:102121 (2025)
Röhrborn, K. et al. Salivary extracellular vesicle-derived microRNAs are related to variances in parameters of obesity, taste and eating behaviour. Mol. Metab. 102:102265 (2025)
Seigner, J. et al. p21-activated kinases (PAKs) regulate FGF1/PDE4D antilipolytic pathway and insulin resistance in adipocytes. Mol. Metab. 99:102210 (2025)
Sulaj, A.* et al. Periodic fasting induced reconstitution of metabolic flexibility improves albuminuria in patients with type 2 diabetes. Mol. Metab. 102:102257 (2025)
Trujillo-Viera, J.* et al. Abundance of a metabolically active subpopulation in dedifferentiated adipocytes inversely correlates with body mass index. Mol. Metab. 97:102161 (2025)
Akindehin, S.E. et al. Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice. Mol. Metab. 83:101915 (2024)
Ayten, M.* et al. Metabolic plasticity in a Pde6bSTOP/STOP retinitis pigmentosa mouse model following rescue. Mol. Metab. 88:101994 (2024)
Contreras, R. et al. HDAC5 controls a hypothalamic STAT5b-TH axis, the sympathetic activation of ATP-consuming futile cycles and adult-onset obesity in male mice. Mol. Metab. 90:102033 (2024)
Cota, P. et al. Insulin regulates human pancreatic endocrine cell differentiation in vitro. Mol. Metab. 79:101853 (2024)
Dragano, N.R.V. et al. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance. Mol. Metab. 79:101840 (2024)
Freire-Agulleiro, Ó.* et al. SF1-specific deletion of the energy sensor AMPKγ2 induces obesity. Mol. Metab. 92:102091 (2024)
Gaugel, J.* et al. Picalm, a novel regulator of GLUT4-trafficking in adipose tissue. Mol. Metab. 88:102014 (2024)
Haas, B.* et al. Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation. Mol. Metab. 85:101956 (2024)
Leiss, V.* et al. Corrigendum to "Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesity" [Mol Metab 40 (2020 Oct) 101029]. Mol. Metab. 82:101910 (2024)
Sandforth, L. et al. Role of human Kallistatin in glucose and energy homeostasis in mice. Mol. Metab. 82:101905 (2024)
Wunderlich, M. et al. Experimental colonization with H. hepaticus, S. aureus and R. pneumotropicus does not influence the metabolic response to high-fat diet or incretin-analogues in wildtype SOPF mice. Mol. Metab. 87:101992 (2024)
Begemann, K.* et al. Rest phase snacking increases energy resorption and weight gain in male mice. Mol. Metab. 69:101691 (2023)
Chovsepian, A. et al. Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status. Mol. Metab. 73:101729 (2023)
Feger, M.* et al. Endothelin receptor B-deficient mice are protected from high-fat diet-induced metabolic syndrome. Mol. Metab. 80:101868 (2023)
Gilly, A. et al. Genome-wide meta-analysis of 92 cardiometabolic protein serum levels. Mol. Metab. 78:101810 (2023)
Liskiewicz, D. et al. Neuronal loss of TRPM8 leads to obesity and glucose intolerance in male mice. Mol. Metab. 72:101714 (2023)
Nieborak, A. et al. Depletion of pyruvate kinase (PK) activity causes glycolytic intermediate imbalances and reveals a PK-TXNIP regulatory axis. Mol. Metab. 74:101748 (2023)
Ouni, M.* et al. Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes. Mol. Metab. 75:101774 (2023)
Shashikadze, B.* et al. Maternal hyperglycemia induces alterations in hepatic amino acid, glucose and lipid metabolism of neonatal offspring: Multi-omics insights from a diabetic pig model. Mol. Metab. 75:101768 (2023)
Wissmiller, K. et al. Inceptor correlates with markers of prostate cancer progression and modulates insulin/IGF1 signaling and cancer cell migration. Mol. Metab. 71:101706 (2023)
Gilly, A. et al. Gene-based whole genome sequencing meta-analysis of 250 circulating proteins in three isolated European populations. Mol. Metab. 61:101509 (2022)
Ha, E.E.* et al. Adipocyte-specific tribbles pseudokinase 1 regulates plasma adiponectin and plasma lipids in mice. Mol. Metab. 56:101412 (2022)
Herzig, S. 10 years of molecular metabolism. Mol. Metab. 63:101547 (2022)
Hrovatin, K. ; Fischer, D.S. & Theis, F.J. Toward modeling metabolic state from single-cell transcriptomics Mol. Metab. 57:101396 (2022)
Kotschi, S.* et al. NFE2L1-mediated proteasome function protects from ferroptosis. Mol. Metab. 57:101436 (2022)
Maity-Kumar, G. et al. Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome. Mol. Metab. 66:101616 (2022)
Oeckl, J.* et al. Loss of UCP1 function augments recruitment of futile lipid cycling for thermogenesis in murine brown fat. Mol. Metab. 61:101499 (2022)
Patel, S.* et al. Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice. Mol. Metab. 65:101589 (2022)
Petrus, P.* et al. Tryptophan metabolism is a physiological integrator regulating circadian rhythms. Mol. Metab. 64:101556 (2022)
Scherm, M.G. et al. Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other. Mol. Metab. 64:101565 (2022)
Tritschler, S. et al. A transcriptional cross species map of pancreatic islet cells. Mol. Metab. 66:101595 (2022)
van Eenige, R.* et al. Angiopoietin-like 4 governs diurnal lipoprotein lipase activity in brown adipose tissue. Mol. Metab. 60:101497 (2022)
Vesting, A.J.* et al. NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition. Mol. Metab. 66:101626 (2022)
Wang, J. et al. PAT2 regulates vATPase assembly and lysosomal acidification in brown adipocytes. Mol. Metab. 61:101508 (2022)
Willemsen, N.* ; Arigoni, I.* ; Studencka-Turski, M.* ; Kruger, E.* & Bartelt, A. Proteasome dysfunction disrupts adipogenesis and induces inflammation via ATF3. Mol. Metab. 62:101518 (2022)
Wolff, G. et al. Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function. Mol. Metab. 60:101487 (2022)
Altamura, S.* et al. Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload. Mol. Metab. 51:101235 (2021)
Chhabra, N.F. et al. A point mutation in the Pdia6 gene results in loss of pancreatic β-cell identity causing overt diabetes. Mol. Metab. 54:101334 (2021)
Fasoula, N.-A. et al. Multicompartmental non-invasive sensing of postprandial lipemia in humans with multispectral optoacoustic tomography. Mol. Metab. 47:101184 (2021)
Gonzales García, I. ; Le Thuc, O. ; Jastroch, M. & García-Cáceres, C. Divide et impera: How mitochondrial fission in astrocytes rules obesity. Mol. Metab. 45:101159 (2021)
Hoene, M.* et al. Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability. Mol. Metab. 54:101359 (2021)
Hörber, S. et al. Hemostatic alterations linked to body fat distribution, fatty liver and insulin resistance. Mol. Metab. 53:101262 (2021)
Klaus, V. et al. Correlation guided Network Integration (CoNI) reveals novel genes affecting hepatic metabolism. Mol. Metab. 53, 101295 (2021)
Lemmer, I.L. ; Willemsen, N.* ; Hilal, N.* & Bartelt, A. A guide to understanding endoplasmic reticulum stress in metabolic disorders. Mol. Metab. 47:101169 (2021)
Novikoff, A. et al. Spatiotemporal GLP-1 and GIPR receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists. Mol. Metab. 49:101181 (2021)
Oppenländer, L. et al. Vertical sleeve gastrectomy triggers fast β-cell recovery upon overt diabetes. Mol. Metab. 54:101330 (2021)
Ruiz Ojeda, F.J. et al. Active integrins regulate white adipose tissue insulin sensitivity and brown fat thermogenesis. Mol. Metab. 45:101147 (2021)
Salinno, C. et al. CD81 marks immature and dedifferentiated pancreatic β-cells. Mol. Metab. 49:101188 (2021)
van Krieken, P.P.* et al. Oncostatin M suppresses browning of white adipocytes via gp130-STAT3 signaling. Mol. Metab. 54:101341 (2021)
Weiner, J.* et al. Leptin counteracts hypothermia in hypothyroidism through its pyrexic effects and by stabilizing serum thyroid hormone levels. Mol. Metab. 54:101348 (2021)
Zeigerer, A. NAFLD - A rising metabolic disease. Mol. Metab. 50:101274 (2021)
Bartke, T. & Schneider, R. You are what you eat-How nutrition and metabolism shape the genome through epigenetics. Mol. Metab. 38:100987 (2020)
Bheda, P. Metabolic transcriptional memory. Mol. Metab. 38:100955 (2020)
Carrat, G.R.* et al. The type 2 diabetes gene product STARD10 is a phosphoinositide-binding protein that controls insulin secretory granule biogenesis. Mol. Metab. 40:101015 (2020)
Erener, S. Diabetes, infection risk and COVID-19. Mol. Metab. 39:101044 (2020)
Fritzen, A.M.* et al. ApoA-1 improves glucose tolerance by increasing glucose uptake into heart and skeletal muscle independently of AMPKα2. Mol. Metab. 35:100949 (2020)
Huang, S.S.Y.* et al. Differential regulation of the immune system in a brain-liver-fats organ network during short-term fasting. Mol. Metab. 40:101038 (2020)
Kaltenecker, D. et al. STAT5 is required for lipid breakdown and beta-adrenergic responsiveness of brown adipose tissue. Mol. Metab. 40:101026 (2020)
Kappel, B.A.* et al. Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment. Mol. Metab. 36:100976 (2020)
Klymenko, O.* et al. Histone deacetylase 5 regulates interleukin 6 secretion and insulin action in skeletal muscle. Mol. Metab. 42:101062 (2020)
Leiss, V.* et al. Lack of Gαi2 proteins in adipocytes attenuates diet-induced obesity. Mol. Metab. 40:101029 (2020)
Lindermayr, C. ; Rudolf, E.E. ; Durner, J. & Groth, M. Interactions between metabolism and chromatin in plant models. Mol. Metab. 38:100951 (2020)
Mziaut, H. et al. MiR-132 controls pancreatic beta cell proliferation and survival through Pten/Akt/Foxo3 signaling. Mol. Metab. 31, 150-162 (2020)
Okun, J.G.* et al. Molecular regulation of urea cycle function by the liver glucocorticoid receptor (vol 4, pg 732, 2015). Mol. Metab. 41:101068 (2020)
Prade, V.M. et al. De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry. Mol. Metab. 36:100953 (2020)
Riedel, E.O.* et al. Functional changes of the liver in the absence of growth hormone (GH) action - Proteomic and metabolomic insights from a GH receptor deficient pig model. Mol. Metab. 36:100978 (2020)
Wittrisch, S.* et al. NPY1R-targeted peptide-mediated delivery of a dual PPAR alpha/gamma agonist to adipocytes enhances adipogenesis and prevents diabetes progression. Mol. Metab. 31, 163-180 (2020)
Backman, M.* et al. Multi-omics insights into functional alterations of the liver in insulin-deficient diabetes mellitus. Mol. Metab. 26, 30-44 (2019)
Bakhti, M. et al. Establishment of a high-resolution 3D modeling system for studying pancreatic epithelial cell biology in vitro. Mol. Metab. 30, 16-29 (2019)
Barovic, M. et al. Metabolically phenotyped pancreatectomized patients as living donors for the study of islets in health and diabetes. Mol. Metab. 27, S1-S6 (2019)
Becker, M. et al. Short-term cold exposure supports human Treg induction in vivo. Mol. Metab. 28, 73-82 (2019)
Gerst, F. et al. What role do fat cells play in pancreatic tissue? Mol. Metab. 25, 1-10 (2019)
Grzybek, M. et al. Comprehensive and quantitative analysis of white and brown adipose tissue by shotgun lipidomics. Mol. Metab. 22, 12-20 (2019)
Harrison, L. ; Pfuhlmann, K. ; Schriever, S.C. & Pfluger, P.T. Profound weight loss induces reactive astrogliosis in the arcuate nucleus of obese mice. Mol. Metab. 24, 149-155 (2019)
Jall, S. et al. Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice. Mol. Metab. 23, 75-81 (2019)
Jall, S. et al. Pirt deficiency has subtle female-specific effects on energy and glucose metabolism in mice (vol 23, pg 75, 2019). Mol. Metab. 30:264 (2019)
Ke, X.* et al. Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice. Mol. Metab. 22, 96-109 (2019)
Keuper, M. et al. Preadipocytes of obese humans display gender-specific bioenergetic responses to glucose and insulin. Mol. Metab. 20, 28-37 (2019)
Khamis, A.* et al. Laser capture microdissection of human pancreatic islets reveals novel eQTLs associated with type 2 diabetes. Mol. Metab. 24, 98-107 (2019)
Kleinert, M. et al. Time-resolved hypothalamic open flow micro-perfusion reveals normal leptin transport across the blood-brain barrier in leptin resistant mice (vol 13, pg 77, 2018). Mol. Metab. 30, 265-265 (2019)
Machado, J. et al. alpha-Calcitonin gene-related peptide inhibits autophagy and calpain systems and maintains the stability of neuromuscular junction in denervated muscles. Mol. Metab. 28, 91-106 (2019)
Mroz, P.A.* et al. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism. Mol. Metab. 20, 51-62 (2019)
Müller, T.D. et al. Glucagon-like peptide 1 (GLP-1). Mol. Metab. 30, 72-130 (2019)
Scherm, M.G. ; Serr, I. ; Kaestner, K.H.* & Daniel, C. The role of T cell miRNAs for regulatory T cell induction in islet autoimmunity. Mol. Metab. 27S, S122-S128 (2019)
Wang, H.* et al. A dual Ucp1 reporter mouse model for imaging and quantitation of brown and brite fat recruitment. Mol. Metab. 20, 14-27 (2019)
Wang, X. et al. Point mutations in the PDX1 transactivation domain impair human beta-cell development and function. Mol. Metab. 24, 80-97 (2019)
Wolff, G.* et al. Diet-dependent function of the extracellular matrix proteoglycan Lumican in obesity and glucose homeostasis. Mol. Metab. 19, 97-106 (2019)
Gerlini, R. et al. Glucose tolerance and insulin sensitivity define adipocyte transcriptional programs in human obesity. Mol. Metab. 18, 42-50 (2018)
Gottmann, P.* et al. A computational biology approach of a genome-wide screen connected miRNAs to obesity and type 2 diabetes. Mol. Metab. 11, 145-159 (2018)
Hinrichs, A.* et al. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver. Mol. Metab. 11, 113-128 (2018)
Hummel, S. et al. Efficacy of vildagliptin for prevention of postpartum diabetes in women with a recent history of insulin-requiring gestational diabetes: A phase II, randomized, double-blind, placebo-controlled study. Mol. Metab. 9, 168-175 (2018)
Kleinert, M. et al. Exercise increases circulating GDF15 in humans. Mol. Metab. 9, 187-191 (2018)
Kleinert, M. et al. Time-resolved hypothalamic open flow micro-perfusion reveals normal leptin transport across the blood-brain barrier in leptin resistant mice. Mol. Metab. 13, 77-82 (2018)
Li, Z.* et al. Periodized low protein-high carbohydrate diet confers potent, but transient, metabolic improvements. Mol. Metab. 17, 112-121 (2018)
Nieborak, A. & Schneider, R. Metabolic intermediates - Cellular messengers talking to chromatin modifiers. Mol. Metab., DOI: 10.1016/j.molmet.2018.01.007 (2018)
Renner, S.* et al. Metabolic syndrome and extensive adipose tissue inflammation in morbidly obese Göttingen minipigs. Mol. Metab., DOI: 10.1016/j.molmet.2018.06.015 (2018)
Sachdeva, R.* et al. TRPC proteins contribute to development of diabetic retinopathy and regulate glyoxalase 1 activity and methylglyoxal accumulation. Mol. Metab. 9, 156-167 (2018)
Schumacher, D.* et al. Compensatory mechanisms for methylglyoxal detoxification in experimental & clinical diabetes. Mol. Metab. 18, 143-152 (2018)
Suwandhi, L. et al. Chronic d-serine supplementation impairs insulin secretion. Mol. Metab., DOI: 10.1016/j.molmet.2018.07.002 (2018)
Walheim, E. ; Wiśniewski, J.R.* & Jastroch, M. Respiromics - An integrative analysis linking mitochondrial bioenergetics to molecular signatures. Mol. Metab. 9, 4-14 (2018)
Wang, X. et al. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors. Mol. Metab. 9, 57-68 (2018)
Yan, X.* et al. Cadm2 regulates body weight and energy homeostasis in mice. Mol. Metab. 8, 180-188 (2018)
Bastidas-Ponce, A. et al. Foxa2 and Pdx1 cooperatively regulate postnatal maturation of pancreatic β-cells. Mol. Metab. 6, 524-534 (2017)
Baumeier, C.* et al. Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease. Mol. Metab. 6, 1254-1263 (2017)
Blutke, A.* et al. The Munich MIDY Pig Biobank - A unique resource for studying organ crosstalk in diabetes. Mol. Metab. 6, 931-940 (2017)
Chen, C. ; Cohrs, C.M. ; Stertmann, J. ; Bozsak, R. & Speier, S. Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis. Mol. Metab. 6, 943-957 (2017)
Frankó, A. et al. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice. Mol. Metab. 6, 256-266 (2017)
Gao, Y. et al. Dietary sugars, not lipids, drive hypothalamic inflammation. Mol. Metab. 6, 897-908 (2017)
Gao, Y.* et al. Deficiency of leptin receptor in myeloid cells disrupts hypothalamic metabolic circuits and causes body weight increase. Mol. Metab. 7, 155-160 (2017)
Ingerslev, B.* et al. Angiopoietin-like protein 4 is an exercise-induced hepatokine in humans, regulated by glucagon and cAMP. Mol. Metab. 6, 1286-1295 (2017)
Jall, S. et al. Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice. Mol. Metab. 6, 440-446 (2017)
Keuper, M. et al. Activated macrophages control human adipocyte mitochondrial bioenergetics via secreted factors. Mol. Metab. 6, 1226-1239 (2017)
Korostylev, A. et al. A high-content small molecule screen identifies novel inducers of definitive endoderm. Mol. Metab. 6, 640-650 (2017)
Lickert, H. & Kaestner, K.H.* Islet biology. Mol. Metab. 6, VI-VI (2017)
Lutz, S.Z. et al. Androgen receptor overexpression in prostate cancer in type 2 diabetes. Mol. Metab. 8, 158-166:doi:10.1016/j.molmet.2017.11.013 (2017)
Maida, A. et al. Repletion of branched chain amino acids reverses mTORC1 signaling but not improved metabolism during dietary protein dilution. Mol. Metab. 6, 873-881 (2017)
Sabrautzki, S. et al. Point mutation of Ffar1 abrogates fatty acid-dependent insulin secretion, but protects against HFD-induced glucose intolerance. Mol. Metab. 6, 1304-1312 (2017)
Schommers, P.* et al. Metformin causes a futile intestinal-hepatic cycle which increase energy expenditure and slows down development of a type 2 diabetes-like state. Mol. Metab. 6, 737-747 (2017)
Teperino, R. Anti-hypertensive treatment in pregnancy impacts offspring growth and metabolism: Q&A. Mol. Metab. 6, 1079-1080 (2017)
Tritschler, S. ; Theis, F.J. ; Lickert, H. & Böttcher, A. Systematic single-cell analysis provides new insights into heterogeneity and plasticity of the pancreas. Mol. Metab. 6, 974-990 (2017)
Enriori, P.J.* et al. α-Melanocyte stimulating hormone promotes muscle glucose uptake via melanocortin 5 receptors. Mol. Metab. 5, 807-822 (2016)
Giroud, M.* et al. miR-125b affects mitochondrial biogenesis and impairs brite adipocyte formation and function. Mol. Metab. 5, 615-25 (2016)
Hausmann, S. & Ussar, S. Insulin receptor trafficking steers insulin action. Mol. Metab. 5, 253-254 (2016)
Klancic, T. ; Woodward, L.* ; Hofmann, S.M. & Fisher, E.A.* High density lipoprotein and metabolic disease: Potential benefits of restoring its functional properties. Mol. Metab. 5, 321-327 (2016)
Kleinert, M. et al. MTORC2 and AMPK differentially regulate muscle triglyceride content via perilipin 3. Mol. Metab. 5, 646-655 (2016)
Kübeck, R.* et al. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice. Mol. Metab. 5, 1162-1174 (2016)
Mziaut, H. et al. The F-actin modifier villin regulates insulin granule dynamics and exocytosis downstream of islet cell autoantigen 512. Mol. Metab. 5, 656-68 (2016)
Ordelheide, A.-M. et al. Granulocyte Colony-Stimulating Factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans. Mol. Metab. 5, 305-316 (2016)
Ost, M.* et al. Muscle mitochondrial stress adaptation operates independently of endogenous FGF21 action. Mol. Metab. 5, 79-90 (2016)
Quarta, C. & Clemmensen, C. Unforeseen role for glucocorticoids in combinatorial anti-obesity pharmacology. Mol. Metab. 5, 435-436 (2016)
Raab, S.* et al. Incretin-like effects of small molecule trace amine-associated receptor 1 agonists. Mol. Metab. 5, 47-56 (2016)
Sánchez-Garrido, M.A. et al. Fibroblast activation protein (FAP) as a novel metabolic target. Mol. Metab. 5, 1015-24 (2016)
Schäfer, M. et al. Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia. Mol. Metab. 5, 67-78 (2016)
Schröder, T.* et al. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. Mol. Metab. 5, 283-295 (2016)
Ussar, S. ; Fujisaka, S.* & Kahn, C.R.* Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome. Mol. Metab. 5, 795-803 (2016)
Ziegler, A.-G. et al. Primary prevention of beta-cell autoimmunity and type 1 diabetes - the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives. Mol. Metab. 5, 255-262 (2016)
Benazra, M.* et al. A human beta cell line with drug inducible excision of immortalizing transgenes. Mol. Metab. 4, 916-925 (2015)
Berti, L. et al. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol. Metab. 4, 519-527 (2015)
Dyar, K.A. et al. The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle. Mol. Metab. 4, 823-833 (2015)
Hansen, J.S.* et al. Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans. Mol. Metab. 4, 551-560 (2015)
Heni, M. et al. Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans. Mol. Metab. 4, 971-976 (2015)
Hofmann, S.M. & Havel, P.J.* The good, the bad, and the unknown: Fructose and FGF21. Mol. Metab. 4, 1-2 (2015)
Jastroch, M. & Andersson, L.B.* When pigs fly, UCP1 makes heat. Mol. Metab. 4, 359-362 (2015)
Kahle-Stephan, M. et al. High fat diet-induced modifications in membrane lipid and mitochondrial-membrane protein signatures precede the development of hepatic insulin resistance in mice. Mol. Metab. 4, 39-50 (2015)
Keipert, S. et al. Genetic disruption of uncoupling protein 1 in mice renders brown adipose tissue a significant source of FGF21 secretion. Mol. Metab. 4, 537-542 (2015)
Migliorini, A. & Lickert, H. Beyond association: A functional role for Tcf7l2 in β-cell development. Mol. Metab. 4, 365-366 (2015)
Müller, T.D. et al. Ghrelin. Mol. Metab. 4, 437–460 (2015)
Okun, J.G.* et al. Molecular regulation of urea cycle function by the liver glucocorticoid receptor. Mol. Metab. 4, 732-740 (2015)
Schriever, S.C. & Pfluger, P.T. Setting the TRAP for central leptin targets. Mol. Metab. 4, 363–364 (2015)
Fischer, K. & Müller, T.D. Relationship status update for PTP1B and LepR: It׳s complicated. Mol. Metab. 3, 217-218 (2014)
Heni, M. et al. Variation in the obesity risk gene FTO determines the postprandial cerebral processing of food stimuli in the prefrontal cortex. Mol. Metab. 3, 109-113 (2014)
Jastroch, M. ; Keipert, S. & Perocchi, F. From explosives to physiological combustion: Next generation chemical uncouplers. Mol. Metab. 3, 86-87 (2014)
Kotzbeck, P. & Zechner, R.* Angiopoietin-like 4: An endogenous break of intestinal lipid digestion. Mol. Metab. 3, 88-89 (2014)
Migliorini, A. ; Bader, E. & Lickert, H. Islet cell plasticity and regeneration. Mol. Metab. 3, 268–274 (2014)
Much, D. ; Beyerlein, A. ; Roßbauer, M. ; Hummel, S. & Ziegler, A.-G. Beneficial effects of breastfeeding in women with gestational diabetes mellitus. Mol. Metab. 3, 284-292 (2014)
Uhlenhaut, N.H. Mix 'n' match estrogens. Mol. Metab. 3, 92-93 (2014)
Ussar, S. Linking maternal obesity to early insulin resistance. Mol. Metab. 3, 219–220 (2014)
Wagner, R.* et al. Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1. Mol. Metab. 3, 261-267 (2014)
Wagner, R. et al. Peroxisome Proliferator-Activated Receptor Gamma (PPARG) modulates Free Fatty Acid Receptor 1 (FFAR1) dependent insulin secretion in humans. Mol. Metab. 3, 676-680 (2014)
Harley, I.T.* et al. Differential colonization with segmented filamentous bacteria and Lactobacillus murinus do not drive divergent development of diet-induced obesity in C57BL/6 mice. Mol. Metab. 2, 171-183 (2013)
Kahle-Stephan, M. et al. Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis. Mol. Metab. 2, 435-446 (2013)
Ordelheide, A.-M. et al. Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion. Mol. Metab. 2, 243-255 (2013)
Ward, B.P.* et al. Peptide lipidation stabilizes structure to enhance biological function. Mol. Metab. 2, 468-479 (2013)
Yi, C.-X. ; Meyer, C.W. & Jastroch, M. Leptin action in the brain: How (and when) it makes fat burn. Mol. Metab. 2, 63-64 (2013)
García-Cáceres, C. ; Fuente-Martin, E.* ; Argente, J.* & Chowen, J.A.* Emerging role of glial cells in the control of body weight. Mol. Metab. 1, 37-46 (2012)
Yi, C.-X. et al. High calorie diet triggers hypothalamic angiopathy. Mol. Metab. 1, 95-100 (2012)